Capromab Pendetide Imaging of Prostate Cancer
Authors:
- Seth A. RosenthalSRSeth A. Rosenthal
- Thomas J. PolascikTPThomas J. Polascik
- 1 April 2000
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 15 (2) , 131-140
Abstract
Capromab Pendetide imaging enables more accurate disease staging in patients with prostate cancer than is afforded by other imaging modalities such as CT and MRI. In the primary disease setting, Capromab Pendetide imaging should be reserved for patients with negative bone scans who are at high risk for metastatic disease. In the recurrent disease setting, this technique is helpful in identifying those patients most likely to respond to salvage therapy. Capromab Pendetide imaging is a technically demanding procedure that is best performed at sites with experience and expertise.Keywords
This publication has 13 references indexed in Scilit:
- SOLITARY PULMONARY METASTASIS FROM PROSTATE CANCERJournal of Urology, 1999
- Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancerUrology, 1999
- A Phase II Study of [ 90 Y] Yttrium-Capromab Pendetide in the Treatment of Men with Prostate Cancer Recurrence Following Radical ProstatectomyCancer Biotherapy and Radiopharmaceuticals, 1999
- Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastasesUrology, 1998
- Radiolabeled Monoclonal Antibody Indium 111-Labeled CYT-356 Localizes Extraprostatic Recurrent Carcinoma After ProstatectomyUrology, 1998
- LONG-TERM RESULTS OF RADIATION THERAPY FOR PROSTATE CANCER RECURRENCE FOLLOWING RADICAL PROSTATECTOMYJournal of Urology, 1998
- Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsCancer, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update1997
- Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissuesUrologic Oncology: Seminars and Original Investigations, 1995
- Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques.Radiology, 1994